• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Insilico Medicine, SK Biopharmaceuticals strike $2.5B AI drug discovery deal targeting neuroimmune therapies
AsiaInsilico Medicine, SK Biopharmaceuticals strike $2.5B AI drug discovery deal targeting neuroimmune therapies
By Nicholas GordonJune 22, 2026
Dr. Shiv Rao speaks
Startups & VentureAbridge wants to be the operating system for medicine—and NVIDIA and Eli Lilly are helping build it
By Lily Mae LazarusJune 11, 2026
Geoffrey von Maltzahn and Kimberly Powell on stage at Fortune Brainstorm Tech
AIAI drug discovery leaders warn U.S. health funding cuts risk falling behind global rivals
By Lily Mae LazarusJune 10, 2026
Novo Nordisk CEO looks beyond weight loss to longevity and aesthetics
HealthNovo Nordisk CEO looks beyond weight loss to longevity and aesthetics
By Madison Muller and BloombergJune 7, 2026
bb
C-SuiteThe CEO who loves AI autodidacts — and desperately needs his experts
By Nick LichtenbergJune 3, 2026
Apoha cofounders Anshika Srivastava (left) and Shamit Shrivastava.
AIExclusive: Apoha, a startup building AI models for creating new materials, emerges from stealth with $36 million in funding
By Jeremy KahnJune 3, 2026
Sanofi is building its own AI ecosystem to give the French pharma giant an edge
NewslettersSanofi is building its own AI ecosystem to give the French pharma giant an edge
By John KellMay 27, 2026
Perceptic cofounders Tilman Flock (left), Zaki Trache (center), and Martin Copes.
AIExclusive: Perceptic, a startup automating drug discovery end-to-end for Big Pharma, emerges from stealth with $12 million in seed funding
By Jeremy KahnMay 26, 2026
Trump points as he speaks with his mouth opened wide
PoliticsWhite House estimates Trump’s Big Pharma dealmaking will save Americans $529 billion over the next 10 years
By Josh Boak and The Associated PressMay 5, 2026
Why an exec at biopharma giant Gilead Sciences prefers energy management over time management
C-SuiteWhy an exec at biopharma giant Gilead Sciences prefers energy management over time management
By Ruth UmohApril 13, 2026
Albert Bourla
SuccessOnly one U.S. university ranks in the world’s top 10 in STEM. Pfizer’s CEO is calling for change
By Preston ForeApril 3, 2026
kennnedy
CommentaryAmerica is handing its mRNA lead to China—and RFK Jr. is to blame
By Jeff CollerMarch 26, 2026
bakker
CommentaryThe $3.4 billion lesson Big Pharma needs to learn: its shelved drugs could save millions of patients
By Annette Bakker and Andrew W. LoMarch 19, 2026
TrumpRx
CommentaryTrumpRx is here and it helps, though a bit less than advertised
By Jeffrey Sonnenfeld, Stephen Henriques, Ferron Chen, Asuka Koda and Vanessa McLennanFebruary 11, 2026
hudson
CommentarySanofi CEO: The enterprise AI shift will reshape pharma in 2026
By Paul HudsonFebruary 10, 2026
1
  • 1
  • 2
  • 3
  • 4
  • 5
...100
Most Popular
Success
After forcing workers back to the office, Goldman Sachs and JPMorgan Chase are now letting their staff work remotely—but only for the World Cupplaceholder alt text
By Orianna Rosa RoyleJune 23, 2026
Banking
Markets tumble worldwide as Fed resets expectations: $400 billion wiped off SpaceX stockplaceholder alt text
By Jim EdwardsJune 23, 2026
Success
Former U.S. Secret Service agent says bringing your authentic self to work stifles teamwork: 'You don’t get high performers, you get sloppiness'placeholder alt text
By Sydney LakeJune 21, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.